<DOC>
	<DOCNO>NCT00599547</DOCNO>
	<brief_summary>The purpose study determine whether reduced intensity condition regimen follow allogeneic stem cell transplantation feasible effective treatment patient primary myelofibrosis .</brief_summary>
	<brief_title>Allogeneic Stem Cell Transplantation ( SCT ) After Dose-reduced Conditioning Myelofibrosis Patients</brief_title>
	<detailed_description>The purpose study determine whether reduced intensity condition regimen follow allogeneic stem cell transplantation relate unrelated donor feasible effective treatment patient primary myelofibrosis .</detailed_description>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<criteria>Disease : Histologically proven Myelofibrosis myeloid metaplasia/MMM define per Italian Consensus Conference MMM diagnosis either primary MMM secondary Polycythaemia vera essential thrombocythaemia `` intermediate risk '' `` high risk '' score accord Lille Scoring System OR `` low risk '' score accord Lille Scoring System constitutional symptom ( fever , night sweat , weight loss &gt; 5 % body weight ) OR `` high risk '' score accord Cervantes score Age : Patients 50 70 year age limit life expectancy reason MMM Patients 50 year age eligible standard myeloablative conditioning , ( e.g. , prior autologous stem cell , history severe infection like fungal infection , history cardiac toxicity reason accord treat physician ) HLA compatible identical donor , relate unrelated ( one mismatch allow ) Written informed consent patient Positive search bcrabl blood . Serious irreversible renal , hepatic , pulmonary cardiac disease Central nervous involvement Positive serology HIV Pregnant lactate woman Patients lifeexpectancy less six month another debilitate disease Serious psychiatric psychological disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
</DOC>